In the following article, the Seville newspaper ABC, speaks of the rapid growth in national and international patent registration by the University of Seville. In the last 5 years, they have gone from providing 44 to 172 patents nationally and from 35 to 200 internationally. Among these patents, we want to highlight the ones for the detection of gluten immunogenic peptides (GIP) in stool and urine, a technology that has been used by Biomedal to develop the iVYDAL in vitro Diagnostics line of products and that is vital to control the gluten-free diet of celiac patients. This technology is being exported to several countries including Germany, the United Kingdom, the United States, Italy, Poland and even China. For more information we leave you the link of the complete news.
